Related Experiment Video

Updated: Mar 26, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.5K

Clinical Evaluation of Pharmacist Interventions in Patients Treated with Anti-methicillin-Resistant Staphylococcus

Naoto Okada1, Shuji Fushitani, Momoyo Azuma

  • 1Department of Pharmacy, Tokushima University Hospital.

Biological & Pharmaceutical Bulletin
|February 3, 2016
PubMed

Insights

Pharmacist interventions significantly increased effective anti-methicillin-resistant Staphylococcus aureus (MRSA) drug concentrations. This proactive approach in hematology wards may improve therapeutic effects and reduce hospitalization for patients with lymphoma.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Clinical Pharmacy

Background:

  • Therapeutic drug monitoring (TDM) is crucial for optimizing anti-methicillin-resistant Staphylococcus aureus (MRSA) agent efficacy.
  • Vancomycin (VCM), teicoplanin (TEIC), and arbekacin (ABK) require precise blood concentrations for therapeutic effect.
  • Implementing TDM protocols is essential in managing MRSA infections, particularly in hematological patients.

Purpose of the Study:

  • To evaluate the clinical effectiveness of pharmacist-led interventions promoting TDM for anti-MRSA agents.
  • To assess the impact of pharmacist interventions on achieving target drug concentrations and patient outcomes.
  • To identify factors influencing hospitalization duration in hematology patients treated with VCM, TEIC, or ABK.

Main Methods:

  • Retrospective study of 145 hematology patients treated with VCM, TEIC, or ABK between January 2012 and December 2013.
  • Comparison of a control group (71 cases) with an intervention group (74 cases) receiving pharmacist-guided TDM.
  • Statistical analysis including univariate and multivariate Cox proportional hazard regression.

Main Results:

  • The intervention group achieved effective drug concentrations at a significantly higher rate (74%) compared to the control group (55%).
  • Pharmacist intervention and appropriate anti-MRSA agent concentrations were independently associated with shorter hospitalization periods.
  • These findings highlight the positive impact of pharmacist involvement in optimizing antibiotic therapy.

Conclusions:

  • Proactive pharmacist interventions significantly enhance the achievement of therapeutic drug concentrations for anti-MRSA agents.
  • Pharmacist-led TDM is an effective strategy to improve clinical outcomes in hematology patients, including reduced hospitalization.
  • Optimizing anti-MRSA agent concentrations through TDM contributes to better patient management and resource utilization.

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.4K
Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Published on: February 9, 2011

23.8K

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
26
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.0K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.9K
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
69